Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary.
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. confirms it will report its preliminary first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. .
Recognition given for achievement in commercializing Joenja® , a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands,.
Pharming To Be Honored As Industry Innovator At National Organization For Rare Disorders (NORD®) 2024 Rare Impact Awards menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Pharming Group N V : Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.